+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients



Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients



Bmc Cancer 15: 690



Asian population has different body mass index (BMI) profile compared to Caucasian population. However, the effect of obesity and body weight gain in Asian colorectal cancer patients treated with adjuvant chemotherapy has not been studied thus far. We have analyzed the association between disease-free survival (DFS) and obesity/body weight change during treatment in Korean stage III or high-risk stage II colorectal cancer patients treated with adjuvant 5-fluorouracil/ leucovorin/oxaliplatin. BMI was classified according to WHO Asia-Pacific classification. Weight change was calculated by comparing body weights measured at the last chemotherapy cycle and before surgery. Among a total of 522 patients, 35.7 % of patients were obese (BMI ≥ 25 kg/m(2)) and 29.1 % were overweight (BMI, 23-24.9 kg/m(2)) before surgery. 18.0 % of patients gained ≥ 5 kg and 26.1 % gained 2-4.9 kg during the adjuvant chemotherapy period. Baseline BMI or body weight change was not associated with DFS in the overall study population. However, body weight gain (≥5 kg) was associated with inferior DFS (adjusted hazard ratio 2.04, 95 % confidence interval 1.02-4.08, p = 0.043) in overweight and obese patients (BMI ≥ 23.0 kg/m(2)). In Korean colorectal cancer patients treated with adjuvant FOLFOX chemotherapy, body weight gain during the treatment period has a negative prognostic influence in overweight and obese patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 058636617

Download citation: RISBibTeXText

PMID: 26467912

DOI: 10.1186/s12885-015-1704-0


Related references

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. European Journal of Cancer 47(17): 2560-2567, 2012

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy. British Journal of Cancer 108(10): 1978-1984, 2013

Prognostic value of body mass index in korean patients with castration-resistant prostate cancer. Korean Journal of Urology 53(11): 761-765, 2012

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. Journal of the National Cancer Institute 98(22): 1647-1654, 2006

The relationship between body weight, body height, body mass index and weight gain during pregnancy. Zeitschrift für Geburtshilfe und Neonatologie 211(4): 147-152, 2007

Correlation between body mass index and prevalence of hereditary nonpolyposis colorectal cancer in Korean patients with endometrial cancer. International Journal of Gynecological Cancer 22(2): 267-272, 2012

Comparisons of body mass index, perception of body weight, body shape satisfaction, and self-esteem among Korean adolescents. Perceptual and Motor Skills 97(3 Pt 2): 1339-1346, 2004

Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery. Interactive Cardiovascular and Thoracic Surgery 23(4): 560-566, 2017

The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients. Breast 23(3): 264-272, 2015

Prepregnancy body mass index and gestational weight gain in relation to child body mass index among siblings. American Journal of Epidemiology 174(10): 1159-1165, 2011

Relationship of body mass index with prognosis in breast cancer patients treated with adjuvant radiotherapy and chemotherapy. Asian Pacific Journal of Cancer Prevention 15(10): 4233-4238, 2015

Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data. Journal of Breast Cancer 15(4): 427-433, 2013

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119(8): 1528-1536, 2013

Effect of Gestational Weight Gain and Prepregnancy Body Mass Index in Adolescent Mothers on Weight and Body Mass Index of Adolescent Offspring. Journal of Adolescent Health 61(5): 626-633, 2017

Polymorphisms of the GR and HSD11B1 genes influence body mass index and weight gain during hormone replacement treatment in patients with Addison's disease. Clinical Endocrinology 85(2): 180-188, 2017